- $113.92m
- $122.24m
- $61.29m
- 26
- 82
- 42
- 48
Annual income statement for Emeren, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 96.9 | 119 | 73.5 | 79.7 | 61.3 |
| Cost of Revenue | |||||
| Gross Profit | 28.1 | 34.2 | 16.7 | 31.4 | 15.3 |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 81.4 | 120 | 66.7 | 67 | 63.9 |
| Operating Profit | 15.5 | -0.964 | 6.78 | 12.7 | -2.63 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 4.91 | -10.6 | 2.32 | 7.39 | -2.63 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 5.1 | -11.7 | 2.16 | 6.61 | -4.55 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | 1.76 | -8.83 | 2.78 | 6.86 | -4.67 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 1.76 | -8.83 | 2.78 | 6.86 | -4.67 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.005 | 0.006 | 0.008 | 0.012 | -0.007 |